Updates in the pathologic diagnosis and classification of epithelial neoplasms of urachal origin

Advances in Anatomic Pathology

Volumn 23, Issue 2, 2016, Pages 71-83

  Paner, Gladell P ^a   Lopez Beltran, Antonio ^c   Sirohi, Deepika ^b   Amin, Mahul B ^b  

^a UNIVERSITY OF CHICAGO   (United States)

^b CEDARS SINAI MEDICAL CENTER   (United States)

^c CHAMPALIMAUD CLINICAL CENTER   (Portugal)

Author keywords

Adenocarcinoma; Bladder; Cancer; Carcinoma; Cystic; Mucinous; Staging; Urachal; Urachus; Urothelial

Indexed keywords

CISPLATIN; FLUOROURACIL; FOLINIC ACID; GEMCITABINE;

BLADDER CANCER; BLADDER CARCINOMA; CANCER CHEMOTHERAPY; CANCER CLASSIFICATION; CANCER DIAGNOSIS; CANCER PROGNOSIS; CANCER STAGING; CLINICAL FEATURE; HISTORY; HUMAN; IMMUNOHISTOCHEMISTRY; MUCINOUS CYSTIC NEOPLASM; NEUROENDOCRINE TUMOR; NONGLANDULAR URACHAL CARCINOMA; PRIORITY JOURNAL; REVIEW; SQUAMOUS CELL CARCINOMA; TRANSITIONAL CELL CARCINOMA; URACHAL ADENOCARCINOMA; URACHAL CARCINOMA; VILLOUS ADENOMA; WORLD HEALTH ORGANIZATION; ADENOCARCINOMA; CLASSIFICATION; URINARY BLADDER NEOPLASMS;

ADENOCARCINOMA; HUMANS; URINARY BLADDER NEOPLASMS;

EID: 84957937035     PISSN: 10724109     EISSN: 15334031     Source Type: Journal    
DOI: 10.1097/PAP.0000000000000110     Document Type: Review

References (90)

1. Begg RC. The urachus: its anatomy, histology and development. Anatomy. 1930;64:170-183.
2. Hammond GYL, Davis JE. The urachus, its anatomy and associated fasciae. Anat Rec. 1941;80:271-287.
3. Blichert-Toft M, Koch F, Nielsen OV. Anatomic variants of the urachus related to clinical appearance and surgical treatment of urachal lesions. Surg Gynecol Obstet. 1973;137:51-54.
4. Schubert GE, Pavkovic MB, Bethke-Bedurftig BA. Tubular urachal remnants in adult bladders. J Urol. 1982;127:40-42.
5. Amin MB, Smith SC, Eble JN, et al. Glandular neoplasms of the urachus: a report of 55 cases emphasizing mucinous cystic tumors with proposed classification. Am J Surg Pathol. 2014;38:1033-1045.
6. Paner GP, Barkan GA, Mehta V, et al. Urachal carcinomas of the nonglandular type: salient features and considerations in pathologic diagnosis. Am J Surg Pathol. 2012;36:432-442.
7. Gopalan A, Sharp DS, Fine SW, et al. Urachal carcinoma: a clinicopathologic analysis of 24 cases with outcome correlation. Am J Surg Pathol. 2009;33:659-668.
8. Dhillon J, Liang Y, Kamat AM, et al. Urachal carcinoma: a pathologic and clinical study of 46 cases. Hum Pathol. 2015;46:1808-1814.
9. Bruins HM, Visser O, Ploeg M, et al. The clinical epidemiology of urachal carcinoma: results of a large, population based study. J Urol. 2012;188:1102-1107.
10. Molina JR, Quevedo JF, Furth AF, et al. Predictors of survival from urachal cancer: a Mayo Clinic study of 49 cases. Cancer. 2007;110:2434-2440.
11. Herr HW, Bochner BH, Sharp D, et al. Urachal carcinoma: contemporary surgical outcomes. J Urol. 2007;178:74-78; discussion 78.
12. Ashley RA, Inman BA, Sebo TJ, et al. Urachal carcinoma: clinicopathologic features and long-term outcomes of an aggressive malignancy. Cancer. 2006;107:712-720.
13. Pinthus JH, Haddad R, Trachtenberg J, et al. Population based survival data on urachal tumors. J Urol. 2006;175:2042-2047; discussion 2047.
14. Wright JL, Porter MP, Li CI, et al. Differences in survival among patients with urachal and nonurachal adenocarcinomas of the bladder. Cancer. 2006;107:721-728.
15. Siefker-Radtke AO, Gee J, Shen Y, et al. Multimodality management of urachal carcinoma: the M. D. Anderson Cancer Center experience. J Urol. 2003;169:1295-1298.
16. Alvarez AP, G P. Surgical pathology of non-neoplastic urachal remnants in pediatric patients. Mod Pathol. 2010;23:174A.
17. Copp HL, Wong IY, Krishnan C, et al. Clinical presentation and urachal remnant pathology: implications for treatment. J Urol. 2009;182:1921-1924.
18. Ueno T, Hashimoto H, Yokoyama H, et al. Urachal anomalies: ultrasonography and management. J Pediatr Surg. 2003;38:1203-1207.
19. Upadhyay V, Kukkady A. Urachal remnants: an enigma. Eur J Pediatr Surg. 2003;13:372-376.
20. Grignon DJ, Ro JY, Ayala AG, et al. Primary adenocarcinoma of the urinary bladder. A clinicopathologic analysis of 72 cases. Cancer. 1991;67:2165-2172.
21. Hue and Jacquin. Cancer colloide de l'ombilic et de la paroi abdominale anterieure ayant envahi la vessie. Union med. 1863;6:418.
22. Brady L. Solid tumors of the urachus. Arch Surg. 1927;19:46-62.
23. Begg RC. The colloid adenocarcinomata of the bladder vault arising from the epithelium of the urachal canal: with a critical survey of the tumours of the urachus. Br J Surg. 1931;18:422-466.
24. Cullen TS. Embryology, Anatomy and Diseases of the Umbilicus Together with Diseases of the Urachus. Philadelphia: W. B. Saunders, 1916:637.
25. Rankin FW, Parker B. Tumors of the urachus; with report of seven cases. Surg Gynecol Obstet. 1926;42:19-27.
26. Wheeler JD, Hill WT. Adenocarcinoma involving the urinary bladder. Cancer. 1954;7:119-135.
27. Mostofi FK, Thomson RV, Dean AL Jr. Mucous adenocarcinoma of the urinary bladder. Cancer. 1955;8:741-758.
28. Sheldon CA, Clayman RV, Gonzalez R, et al. Malignant urachal lesions. J Urol. 1984;131:1-8.
29. Anderstrom C, Johansson SL, von Schultz L. Primary adenocarcinoma of the urinary bladder. A clinicopathologic and prognostic study. Cancer. 1983;52:1273-1280.
30. Johnson DE, Hogan JM, Ayala AG. Primary adenocarcinoma of the urinary bladder. South Med J. 1972;65:527-530.
31. Johnson DE, Hodge GB, Abdul-Karim FW, et al. Urachal carcinoma. Urology. 1985;26:218-221.
32. Eble JN, Sauter G, Epstein JI, et al. World Health Organization Classification of Tumours. Pathology & Genetics. New York: WHO Publication Center; 2004.
33. Munichor M, Szvalb S, Cohen H, et al. Mixed adenocarcinoma and neuroendocrine carcinoma arising in the urachus. A case report and review of the literature. Eur Urol. 1995;28:345-347.
34. Abenoza P, Manivel C, Sibley RK. Adenocarcinoma with neuroendocrine differentiation of the urinary bladder. Clinicopathologic, immunohistochemical, and ultrastructural study. Arch Pathol Lab Med. 1986;110:1062-1066.
35. Chow YC, Lin WC, Tzen CY, et al. Squamous cell carcinoma of the urachus. J Urol. 2000;163:903-904.
36. Lee BT, Lefor AT, Didolkar MS. Squamous cell carcinoma of the umbilicus associated with acquired immune deficiency syndrome. J Surg Oncol. 1991;47:67-69.
37. Lin RY, Rappoport AE, Deppisch LM, et al. Squamous cell carcinoma of the urachus. J Urol. 1977;118:1066-1067.
38. Pujari BD, Phansopkar M, Deodhare SG. Squamous cell carcinoma of the urachus with vesical calculus. Br J Urol. 1977;49:292.
39. Rubin JP, Kasznica JM, Davis CA 3rd, et al. Transitional cell carcinoma in a urachal cyst. J Urol. 1999;162:1687-1688.
40. Satake I, Nakagomi K, Tari K, et al. Metachronous transitional cell carcinoma of the urachus and bladder. Br J Urol. 1995;75:244.
41. Irwin PP, Weston PM, Sheridan W, et al. Transitional cell carcinoma arising in a urachal cyst. Br J Urol. 1991;67:103-104.
42. Lyth DR, Booth CM. Transitional cell carcinoma of the urachus. Br J Urol. 1990;65:544-545.
43. Hayman J. Carcinoma of the urachus. Pathology. 1984;16:167-171.
44. Fisher ER. Transitional-cell carcinoma of the urachal apex. Cancer. 1958;11:245-249.
45. Shaw RE. Squamous-cell carcinoma in a cyst of the urachus. Br J Urol. 1958;30:87-89.
46. Seibel JL, Prasad S, Weiss RE, et al. Villous adenoma of the urinary tract: a lesion frequently associated with malignancy. Hum Pathol. 2002;33:236-241.
47. Cheng L, Montironi R, Bostwick DG. Villous adenoma of the urinary tract: a report of 23 cases, including 8 with coexistent adenocarcinoma. Am J Surg Pathol. 1999;23:764-771.
48. Eble JN, Hull MT, Rowland RG, et al. Villous adenoma of the urachus with mucusuria: a light and electron microscopic study. J Urol. 1986;135:1240-1244.
49. Carr NJ, McLean AD. A mucinous tumour of the urachus: adenoma or low grade mucinous cystic tumour of uncertain malignant potential? Adv Clin Pathol. 2001;5:93-97.
50. Hubens G, De Vries D, Hauben E, et al. Laparoscopic resection of an adenoma of the urachus in combination with a laparoscopic cholecystectomy. Surg Endosc. 1995;9:914-916.
51. Hull MT, Warfel KA. Urachal cystadenoma with abundant glycogen: ultrastructural study. Ultrastruct Pathol. 1994;18:499-502.
52. Elliott GB, Freigang B. Observations on the nature of mucin secreting urachal cystadenoma. Ann Surg. 1963;157:613-617.
53. Hamm FC. Benign cystadenoma of the bladder. J Urol. 1940;44:227-233.
54. Sung W, Park BD, Lee S, et al. Villous adenoma of the urinary bladder. Int J Urol. 2008;15:551-553.
55. Joniau S, Lerut E, Van Poppel H. A giant mucinous adenocarcinoma arising within a villous adenoma of the urachus: case report and review of the literature. Case Rep Med. 2009;2009:818646.
56. Macher-Goeppinger S, Aulmann S, Haferkamp A, et al. [Villous adenoma within an urachal diverticulum associated with long-term mucusuria]. Pathologe. 2008;29:305-307.
57. Tzortzis V, Ioannou M, Melekos MD. Villous adenoma of the urachus: a case with prostate specific antigen immunoreactivity. J Urol. 2003;170:1302-1303.
58. Mazzucchelli R, Scarpelli M, Montironi R. Mucinous adenocarcinoma with superficial stromal invasion and villous adenoma of urachal remnants: a case report. J Clin Pathol. 2003;56:465-467.
59. Channer JL, Williams JL, Henry L. Villous adenoma of the bladder. J Clin Pathol. 1993;46:450-452.
60. Lim M, Adsay NV, Grignon D, et al. Urothelial carcinoma with villoglandular differentiation: a study of 14 cases. Mod Pathol. 2009;22:1280-1286.
61. Chan TY, Epstein JI. In situ adenocarcinoma of the bladder. Am J Surg Pathol. 2001;25:892-899.
62. Miller JS, Epstein JI. Noninvasive urothelial carcinoma of the bladder with glandular differentiation: report of 24 cases. Am J Surg Pathol. 2009;33:1241-1248.
63. Paner GP, McKenney JK, Barkan GA, et al. Immunohistochemical analysis in a morphologic spectrum of urachal epithelial neoplasms: diagnostic implications and pitfalls. Am J Surg Pathol. 2011;35:787-798.
64. Grignon DJ, Ro JY, Ayala AG, et al. Primary signet-ring cell carcinoma of the urinary bladder. Am J Clin Pathol. 1991;95:13-20.
65. Thomas AA, Stephenson AJ, Campbell SC, et al. Clinicopathologic features and utility of immunohistochemical markers in signet-ring cell adenocarcinoma of the bladder. Hum Pathol. 2009;40:108-116.
66. Bissonnette ML, Kocherginsky M, Tretiakova M, et al. The different morphologies of urachal adenocarcinoma do not discriminate genomically by micro-RNA expression profiling. Hum Pathol. 2013;44:1605-1611.
67. Sirintrapun SJ, Ward M, Woo J, et al. High-stage urachal adenocarcinoma can be associated with microsatellite instability and KRAS mutations. Hum Pathol. 2014;45:327-330.
68. Hutchinson LPGP, Tomaszewicz K, Mehta K, et al. KRAS is mutated in a subset of mucinous type urachal adenocarcinomas. Mod Pathol. 2012;25:214A.
69. Lane Z, Hansel DE, Epstein JI. Immunohistochemical expression of prostatic antigens in adenocarcinoma and villous adenoma of the urinary bladder. Am J Surg Pathol. 2008;32:1322-1326.
70. Kipp BR, Tyner HL, Campion MB, et al. Chromosomal alterations detected by fluorescence in situ hybridization in urothelial carcinoma and rarer histologic variants of bladder cancer. Am J Clin Pathol. 2008;130:552-559.
71. Henly DR, Farrow GM, Zincke H. Urachal cancer: role of conservative surgery. Urology. 1993;42:635-639.
72. American Joint Committee on Cancer. AJCC Cancer Staging Manual. 7th Ed. New York: Springer, 2010.
73. Siefker-Radtke A. Urachal adenocarcinoma: a clinician's guide for treatment. Semin Oncol. 2012;39:619-624.
74. Siefker-Radtke A. Urachal carcinoma: surgical and chemotherapeutic options. Expert Rev Anticancer Ther. 2006;6:1715-1721.
75. Yanagihara Y, Tanji N, Miura N, et al. Modified FOLFOX6 chemotherapy in patients with metastatic urachal cancer. Chemotherapy. 2013;59:402-406.
76. Martinez A, Ferron G, Mery E, et al. Peritoneal pseudomyxoma arising from the urachus. Surg Oncol. 2012;21:1-5.
77. Sugarbaker PH, Verghese M, Yan TD, et al. Management of mucinous urachal neoplasm presenting as pseudomyxoma peritonei. Tumori. 2008;94:732-736.
78. Soto Delgado M, Pedrero Marquez G, Varo Solis C, et al. Mucinous adenocarcinoma of the urachus and peritoneal pseudomyxoma. Actas Urol Esp. 2006;30:222-226.
79. Shinohara T, Misawa K, Sano H, et al. Pseudomyxoma peritonei due to mucinous cystadenocarcinoma in situ of the urachus presenting as an inguinal hernia. Int J Clin Oncol. 2006;11:416-419.
80. Stenhouse G, McRae D, Pollock AM. Urachal adenocarcinoma in situ with pseudomyxoma peritonei: a case report. J Clin Pathol. 2003;56:152-153.
81. de Bree E, Witkamp A, Van De Vijver M, et al. Unusual origins of Pseudomyxoma peritonei. J Surg Oncol. 2000;75:270-274.
82. Pedersen GL, Dahl C, Azawi NH. Non-invasive, low-grade papillary urothelial carcinoma in the urachus. BMJ Case Reports. 2013;2013:bcr2013200635.
83. Andrei S, Andrei A, Rusu Muntean G, et al. A rare case of metastatic squamous urachal carcinoma. Chirurgia (Bucur). 2013;108:280-284.
84. Maletic V, Cerovic S, Lazic M, et al. Synchronous and multiple transitional cell carcinoma of the bladder and urachal cyst. Int J Urol. 2008;15:554-556.
85. Lara C, Porras V, Jurado P, et al. Papillary urothelial carcinoma of the urachus. Arch Esp Urol. 2006;59:914-916.
86. Kuramoto T, Kikkawa K, Nishihata M, et al. Squamous cell carcinoma of the urachus producing granulocyte colonystimulating factor. Urology. 2009;73:442. e445-447.
87. Fujiyama C, Nakashima N, Tokuda Y, et al. Squamous cell carcinoma of the urachus. Int J Urol. 2007;14:966-968.
88. Kodali S, Ratnasabapathy C, Sivamurthy S. Metastatic squamous cell carcinoma of the urachus. Clin Adv Hematol Oncol. 2007;5:887-889. discussion 889, 919.
89. Soni HC, Marda S, Goswami KG, et al. Transitional cell carcinoma in urachal cyst. Abdom Imaging. 2010;35:764-766.
90. Nese N, Kesici G, Lekili M, et al. Urachal urothelial carcinoma diagnosed at a radical prostatectomy operation: a case report. Anal Quant Cytol Histol. 2010;32:174-177.